MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® Injectable to saline placebo in the treatment of Achilles Tendonitis....
MiMedx commenced a Phase III study to evaluate AmnioFix Injectable allograft vs. placebo in the treatment of Plantar Fasciitis. ...
AlloSource launched AlloFuse® Select CM cellular allograft for use in spinal, orthopaedic and neurologic procedures. ...
Anika Therapeutics received regulatory approval in India for MONOVISC® viscosupplement to treat OA pain in all synovial joints....
A 6-year, randomized clinical trial is underway to evaluate use of a patient’s own stem cells to regenerate knee cartilage....
Histogenics completes enrollment of 245 patients in its NeoCart Phase III clinical trial....
ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware portfolio....
Bone Therapeutics received notice that the European Patent Office will grant the company a patent covering its allogeneic cell therapy...
Carmell Therapeutics was issued Canada Patent No. 2,701,187, addressing Methods and Apparatus for Manufacturing Plasma Based Plastics....
Creative Medical filed two patent applications regarding use of immune system cells to stimulate blood vessel formation for the treatment of lower...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.
0 
